Epidemiology of Cryptococcosis Among Patients With Commercial Health Insurance and Patients With Medicaid, United States, 2016

Epidemiology of Cryptococcosis Among Patients With Commercial Health Insurance and Patients With Medicaid, United States, 2016–2022

Published:2024-04-26 Issue:5 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Benedict Kaitlin¹^ORCID,Smith Dallas J¹,Gold Jeremy A W¹

Affiliation:

1. Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA

Abstract

Abstract In 2 large health insurance claims databases, cryptococcosis prevalence was 3.4 cases per 100 000 commercially insured patients and 6.5 per 100 000 Medicaid patients. Prevalence was higher among males, non-Hispanic Black patients, and residents of the Southern United States, likely reflecting the disproportionate burden of HIV in these populations.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae260/57420050/ofae260.pdf

Reference19 articles.

1. MSG07: an International Cohort Study comparing epidemiology and outcomes of patients with Cryptococcus neoformans or Cryptococcus gattii infections;Baddley;Clin Infect Dis,2021

2. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis;Rajasingham;Lancet Infect Dis,2022

3. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant;Bratton;PLoS One,2012

4. Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated cryptococcosis: a population-based study;George;Clin Infect Dis,2018

5. Epidemiology of cryptococcal meningitis in the US: 1997–2009;Pyrgos;PLoS One,2013